相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Vernal keratoconjunctivitis: an update
Stefan De Smedt et al.
BRITISH JOURNAL OF OPHTHALMOLOGY (2013)
Nasal High-Mobility Group Box-1 Protein in Children with Allergic Rhinitis
C. Salpietro et al.
INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY (2013)
The Receptor for Advanced Glycation End Products Is a Central Mediator of Asthma Pathogenesis
Pavle S. Milutinovic et al.
AMERICAN JOURNAL OF PATHOLOGY (2012)
HMGB1 and RAGE levels in induced sputum correlate with asthma severity and neutrophil percentage
Ying Zhou et al.
HUMAN IMMUNOLOGY (2012)
New insights into childhood Vernal keratoconjunctivitis-associated factors
Riccardina Tesse et al.
PEDIATRIC ALLERGY AND IMMUNOLOGY (2012)
Transforming growth factor-beta/Smad - signalling pathway and conjunctival remodelling in vernal keratoconjunctivitis
A. Leonardi et al.
CLINICAL AND EXPERIMENTAL ALLERGY (2011)
Solution Structure of the Soluble Receptor for Advanced Glycation End Products (sRAGE)
Zsuzsa Sarkany et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
Increased levels of HMGB-1 and endogenous secretory RAGE in induced sputum from asthmatic patients
Tetsuya Watanabe et al.
RESPIRATORY MEDICINE (2011)
HMGB1 and RAGE in Inflammation and Cancer
Gary P. Sims et al.
ANNUAL REVIEW OF IMMUNOLOGY, VOL 28 (2010)
Reciprocal interaction of the conjunctiva and cornea in ocular allergy
Ken Fukuda et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2010)
Treatment of severe vernal keratoconjunctivitis with 1% topical cyclosporine in an Italian cohort of 197 children
Riccardina Tesse et al.
PEDIATRIC ALLERGY AND IMMUNOLOGY (2010)
High-Mobility Group Box 1 Promotes Metalloproteinase-9 Upregulation Through Toll-Like Receptor 4 After Cerebral Ischemia
Jianhua Qiu et al.
STROKE (2010)
High mobility group box 1 potentiates the pro-inflammatory effects of interleukin-1 beta in osteoarthritic synoviocytes
Isabel Garcia-Arnandis et al.
ARTHRITIS RESEARCH & THERAPY (2010)
Soluble receptor for advanced glycation end products: a new biomarker in diagnosis and prognosis of chronic inflammatory diseases
Helene Maillard-Lefebvre et al.
RHEUMATOLOGY (2009)
Efficacy of 1.25% and 1% topical cyclosporine in the treatment of severe vernal keratoconjunctivitis in childhood
Laura Spadavecchia et al.
PEDIATRIC ALLERGY AND IMMUNOLOGY (2006)
The nuclear protein HMGB1 as a proinflammatory mediator
HE Harris et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2004)
Predominance of infiltrating IL-4-producing T cells in conjunctiva of patients with allergic conjunctival disease
N Matsuura et al.
CURRENT EYE RESEARCH (2004)
Atopy and serum eosinophil cationic protein in 110 white children with vernal keratoconjunctivitis: differences between tarsal and limbal forms
N Pucci et al.
CLINICAL AND EXPERIMENTAL ALLERGY (2003)
Mechanisms and comparison of anti-allergic efficacy of topical lodoxamide and cromolyn sodium treatment in vernal keratoconjunctivitis
AM Avunduk et al.
OPHTHALMOLOGY (2000)
Vernal keratoconjunctivitis revisited - A case series of 195 patients with long-term follow-up
S Bonini et al.
OPHTHALMOLOGY (2000)
Tear and serum soluble leukocyte activation markers in conjunctival allergic diseases
A Leonardi et al.
AMERICAN JOURNAL OF OPHTHALMOLOGY (2000)
分享论文
